Animal models for muscular dystrophy: valuable tools for the development of therapies

By Allamand Valérie   Campbell KevinP.  

Human Molecular Genetics, Vol. 9, Iss. 16, 2000-10 ,pp. : 2459-2467

Oxford University Press

Access to resources Recommend Favorite

Matrix metalloproteinase-9 inhibition ameliorates pathogenesis and improves skeletal muscle regeneration in muscular dystrophy

By Li Hong   Mittal Ashwani   Makonchuk Denys Y.   Bhatnagar Shephali   Kumar Ashok  

Human Molecular Genetics, Vol. 18, Iss. 14, 2009-07 ,pp. : 2584-2598

Oxford University Press

Access to resources Recommend Favorite

Ku70 regulates Bax-mediated pathogenesis in laminin-2-deficient human muscle cells and mouse models of congenital muscular dystrophy

By Vishnudas Vivek K.   Miller Jeffrey Boone  

Human Molecular Genetics, Vol. 18, Iss. 23, 2009-12 ,pp. : 4467-4477

Oxford University Press

Access to resources Recommend Favorite

Evaluation of the therapeutic potential of carbonic anhydrase inhibitors in two animal models of dystrophin deficient muscular dystrophy

By Giacomotto Jean   Pertl Cordula   Borrel Caroline   Walter Maggie C.   Bulst Stefanie   Johnsen Bob   Baillie David L.   Lochmller Hanns   Thirion Christian   Sgalat Laurent  

Human Molecular Genetics, Vol. 18, Iss. 21, 2009-11 ,pp. : 4089-4101

Oxford University Press

Access to resources Recommend Favorite

Activation of MAPK in hearts of EMD null mice: similarities between mouse models of X-linked and autosomal dominant EmeryDreifuss muscular dystrophy

By Muchir Antoine   Pavlidis Paul   Bonne Gisle   Hayashi Yukiko K.   Worman Howard J.  

Human Molecular Genetics, Vol. 16, Iss. 15, 2007-08 ,pp. : 1884-1895

Oxford University Press

Access to resources Recommend Favorite